Invent medic Sweden AB’s (“Invent Medic”) clinical multicenter-study is in its final stretch with all patients recruited. The final patient data are due after the holidays and thereafter will the results be analyzed and compiled into the technical file and CE-process.
Invent medic Sweden AB’s (“invent medic”) clinical study coordinated by senior physician Aino Fianu Jonasson at Karolinska University Hospital in Stockholm is in its final stretch. The last of the 96 patients has been recruited, and data are due after the weekends. Thereafter the results will be processed and together with results from other studies on the product compiled and reviewed by the company’s notified Body (NB) before a CE process which is a prerequisite for launching the TVS on the market.
Karin Bryder, CEO of Invent Medic, comments:
“Since we initiated the clinical study of the TVS, we have experienced a great deal of interest from both clinicians and patients. I am pleased to see that the study is now being finalized and I look forward to the results with excitement. “